European Federation of Neurological Societies/Peripheral Nerve Society Guideline* on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society
Author:
- Joint Task Force Of The Efns And The PnsJPJoint Task Force Of The Efns And The Pns
- 1 September 2005
- journal article
- practice guideline
- Published by Wiley in Journal of the Peripheral Nervous System
- Vol. 10 (3) , 220-228
Abstract
Abstract Background: Numerous sets of diagnostic criteria have sought to define chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), and randomized trials and systematic reviews of treatment have been published. Objectives: The aim of this guideline was to prepare consensus guidelines on the definition, investigation, and treatment of CIDP. Methods: Disease experts and a representative of patients considered references retrieved from MEDLINE and Cochrane Systematic Reviews in May 2004 and prepared statements that were agreed in an iterative fashion. Recommendations: The Task Force agreed on good practice points to define clinical and electrophysiological diagnostic criteria for CIDP with or without concomitant diseases and investigations to be considered. The principal treatment recommendations were as follows: (1) intravenous immunoglobulin (IVIg) or corticosteroids should be considered in sensory and motor CIDP (level B recommendation); (2) IVIg should be considered as the initial treatment in pure motor CIDP (good practice point); (3) if IVIg and corticosteroids are ineffective, plasma exchange should be considered (level A recommendation); (4) if the response is inadequate or the maintenance doses of the initial treatment are high, combination treatments or adding an immunosuppressant or immunomodulatory drug should be considered (good practice point); and (5) symptomatic treatment and multidisciplinary management should be considered (good practice point).Keywords
This publication has 22 references indexed in Scilit:
- Guidance for the preparation of neurological management guidelines by EFNS scientific task forces – revised recommendations 2004*European Journal of Neurology, 2004
- Corticosteroid use in the treatment of neuromuscular disorders: Empirical and evidence‐based dataMuscle & Nerve, 2004
- Treatment of chronic inflammatory demyelinating polyneuropathy with interferon-α 2aNeurology, 1998
- A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathyAnnals of Neurology, 1994
- Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)Neurology, 1991
- Chronic Inflammatory Demyelinating PolyradiculoneuropathyArchives of Neurology, 1989
- Plasma Exchange in Chronic Inflammatory Demyelinating PolyradiculoneuropathyNew England Journal of Medicine, 1986
- Combined azathioprine and prednisone in chronic inflammatory‐demyelinating polyneuropathyNeurology, 1985
- Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatmentAnnals of Neurology, 1982